Morgan Stanley
MR

Morgan Stanley’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Morgan Stanley’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-987,447
Closed -$26.8M – 6929
2015
Q4 		$26.8M Buy
987,447
+973,320
+6,890% +$25.1M 0.01% 1194
2015
Q3 		$308K Sell
14,127
-11,810
-46% -$301K ﹤0.01% 4874
2015
Q2 		$740K Sell
25,937
-79,697
-75% -$2.32M ﹤0.01% 4425
2015
Q1 		$2.89M Sell
105,634
-242,615
-70% -$6.68M ﹤0.01% 3234
2014
Q4 		$9.19M Buy
348,249
+243,816
+233% +$7.14M ﹤0.01% 2147
2014
Q3 		$3.15M Buy
104,433
+10,219
+11% +$316K ﹤0.01% 3053
2014
Q2 		$2.97M Sell
94,214
-74,960
-44% -$2.38M ﹤0.01% 3159
2014
Q1 		$5.47M Sell
169,174
-360,149
-68% -$12.6M ﹤0.01% 2507
2013
Q4 		$19.2M Buy
529,323
+59,793
+13% +$2.32M 0.01% 1376
2013
Q3 		$18.3M Sell
469,530
-473,708
-50% -$19.1M 0.01% 1294
2013
Q2 		$35.3M Buy
+943,238
New +$37.2M 0.02% 815

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley's MR Position: Q1 2016 in Review

Morgan Stanley sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 987,447 shares — an estimated $26.8M sold.

Morgan Stanley first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $35.3M in Q2 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Morgan Stanley reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Morgan Stanley sold 987,447 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $26.8M.
  • Morgan Stanley first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Morgan Stanley's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $35.3M in Q2 2013.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Morgan Stanley's 13F filing for Q1 2016, filed 12 May 2016.